Effect of oral L-carnitine on echocardiography of dialysis patients

Phase 3

Recruiting

• Conditions: pulmonary hypertension.; Other secondary pulmonary hypertension; I27.2

• Registration Number: IRCT20230425057989N1
• Lead Sponsor: Shahre-kord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

More than 13 years of age
History of at least six months of hemodialysis
Having a case in the dialysis department
Performing dialysis 2 or 3 times a week for 3-4 hours each time
Not having physical and mental disabilities
The patient's dry weight remains constant

Exclusion Criteria

Suffering from chronic physical disorders such as heart, respiratory, and liver diseases
Kidney transplant history
Unwillingness to continue cooperation
Death
Travel
Occurrence of unwanted drug side effects
Not taking medicine for more than a week

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pulmonary artery pressure. Timepoint: Before and after 3 months from the start of the intervention. Method of measurement: Echocardiography.;Arterial oxygen saturation. Timepoint: Before and after 3 months from the start of the intervention. Method of measurement: Pulse oximetry.

Secondary Outcome Measures

Name	Time	Method
umber of times of hemodialysis per week. Timepoint: Before and after 3 months from the start of the intervention. Method of measurement: Number of times of hemodialysis per week.;Right ventricular function. Timepoint: Before and after 3 months from the start of the intervention. Method of measurement: Echocardiography.;Shortness of breath. Timepoint: Before and after 3 months from the start of the intervention. Method of measurement: NYHA (New York Heart Association Functional Classification).